Run a boutique communications firm. Also a diehard SU hoops fan. My tweets are my views alone.
PA
Joined January 2009
- Tweets4.4K
- Following582
- Followers868
- Likes4.1K
Pro tip: don’t buy a pair of @hoka and wait a while to use them. I did and both shoes are falling apart. Company said they’re not covered under warranty. ☹️
Tony Plohoros retweeted
🏆🏀 Huge congrats to the winners of our #MarchMadness Bracket Challenge! 🏀🏆
Big thanks to everyone for joining the fun. The competition was tough!
🎉 Our top three players win charitable donations to their chosen causes:
1️⃣ Chris Licata
2️⃣ Rick Sauter
3️⃣ Chris Bowe
I love @Hoka, but bought a pair a while ago & noticed BOTH shoes were ripping after wearing them only a few times INSIDE at the gym. Sent them back & got a letter saying they were out of warranty. Maybe, but the "old" shoes are defective! Expected better from a premium brand.☹️
Tony Plohoros retweeted
Congrats to our #client Jupiter Bioventures and founders @NathanielEDavid and @nes047 on its launch! This new #biotech venture foundry raised $70M to advance 8-10 companies in #cancer and other diseases where cancer biology provides insight. endpts.com/jupiter-bioventur…
Tony Plohoros retweeted
CVS store-brand drugs are a few dollars cheaper and consumers could assume they're the same as the big, name brand ones. Mold, bacteria and barefoot factory workers say otherwise.
Read my latest investigation: bloom.bg/45hcae9
Tony Plohoros retweeted
Atsena Therapeutics (#client) announced positive results from a #clinicaltrial for the treatment of GUCY2D-associated LCA1, which was one of many exciting developments in the ophthalmologic space announced during #AAO2022. Read more: bit.ly/3EmLptd
Tony Plohoros retweeted
Welcome to Twitter to #client @NacuityPharma! We look forward to updates on Nacuity's work to treat #eyediseases and other chronic conditions caused by #oxidativestress.
Follow our progress in developing innovative treatments for #oxidativestress, a driver of blinding #eyediseases and other conditions. Currently, we are advancing our treatments for #retinitispigmentosa, #cataract, and cystinosis with key backing from @FightBlindness’ @RD_Fund 👁️
Tony Plohoros retweeted
Great piece on the long history of #phageTherapy with a quote from #client @LocusBio’s CEO Paul Garofolo discussing Locus’ role in realizing the full potential of #bacteriophage #precisionmedicine to fight #infectiousdisease genengnews.com/topics/transl…
Tony Plohoros retweeted
Join our team! We're looking for an Account Director to join our #WFH team of dynamic communication professionals passionate about providing strategic counsel and support to our clients in the #lifesciences industry. Learn more and apply: bit.ly/3vjH3Oo #biotech
Tony Plohoros retweeted
In this episode of the @GlobalGenes #RAREcast podcast, listen to Dr. Ben Yerxa, CEO of @OpusGenetics, talk about the company’s patient-centric approach and #genetherapy programs for rare inherited #retinaldiseases: bit.ly/3bdwjKn
Tony Plohoros retweeted
Research Triangle Park has been named a top #biotech hub in the US. With 790 life sciences companies and counting, #RTP is a haven for #innovation and home to many of our clients. Read more: bit.ly/3yISuBe
Tony Plohoros retweeted
From IT to #biopharma--learn how Paul Garofolo's career trajectory landed him at the head of @LocusBio, a company revolutionizing the treatment of disease with novel #precisionmedicines. Listen to his interview on the @Biotech2050Pod: bit.ly/3MoJWTO
It was a pleasure to host Paul Garofolo, CEO @LocusBio!
Hear how Paul is leaning on his past experience @Patheon among others to help Locus develop #precisionmedicine to combat #infectiousdisease!
bit.ly/3MoJWTO
#podcast #academia #ecoli @NCState
Tony Plohoros retweeted
Learn more about @Humacyte’s #regenmed technology and how Ukrainian surgeons are leveraging its investigational human acellular vessel to treat wartime #vasculartrauma injuries in the latest @dslevine The Bio Report podcast with $HUMA CEO @DrLauraNiklason: bit.ly/3ztO02b
.@DrLauraNiklason @humacyte discusses the company’s experimental human acellular vessels, the potential needs they can address, and a real-world test of them as they are being used to treat war-wounded civilians and soldiers in Ukraine.
soundcloud.com/levine-media-…
Tony Plohoros retweeted
Get a closer look at @LocusBio's recent $35M funding and its implications for the field #biotherpeutics and the @NCbiotech community. Read more in @WRALTechWire: bit.ly/3NBmIdV
Inside Locus Biosciences' $35M funding: What it means for gene editing startup in RTP #WRALTechWire wraltechwire.com/2022/05/26/…
Tony Plohoros retweeted
Watch @WNCN’s interview with #client @Humacyte’s CEO @DrLauraNiklason on the recently launched initiative to send bioengineered blood vessels to hospitals in @Ukraine for wartime injuries ⬇️
Durham company sends engineered blood vessels to Ukraine to help people injured in war trib.al/5m5Oa1D
Tony Plohoros retweeted
Good luck to our CEO @MLehrPHL as a @PhilaPACT 2022 Life Sciences & Healthcare CEO of the Year finalist, a well-deserved recognition of his #leadership in #lifesciences. Congratulations to all the finalists working to make a difference! $CNTX philadelphiapact.com/enterpr…
Tony Plohoros retweeted
We are thrilled to report that our shipment of HAVs has safely arrived in the hands of brave medical professionals in @Ukraine. It is truly an honor to provide these potentially life-saving vessels in this humanitarian effort to aid in medical relief during these conflicts.
ALT Photos of Humacyte's HAVs leaving the North Carolina headquarters and arriving at a medical storage phacility in Ukraine, along with a quote from the Ministry of Health of Ukraine.
Tony Plohoros retweeted
Very exciting news coming from #client Inceptor Bio, who announced today the closing of a $37 million Series A financing, which will be used to advance its novel CAR-T, CAR-M and CAR-NK platforms into the clinic. bit.ly/3LsIwa7